2022 FSHD Society International Research Congress AOC 1020: An Antibody Oligonucleotide Conjugate (AOC) in Development for the Treatment of FSHD Inpatient Admissions and Emergency Department Visits for Patients with Facioscapulohumeral Muscular Dystrophy (FSHD): A Real-World Retrospective Data Analysis of Pre- and Post-Diagnosis Events